Surface changes in adult Fasciola hepatica following treatment in vivo with the experimental fasciolicide, compound alpha

Parasitology Research

Volumn 105, Issue 3, 2009, Pages 757-767

  McConville, M ^a   Brennan, G P ^a   Flanagan, A ^a   Hanna, R E B ^b   Edgar, H W J ^b   Castillo, R ^c   Hernandez Campos A ^c   Fairweather, I ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b AGRI FOOD AND BIOSCIENCES INSTITUTE   (United Kingdom)

^c UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

FASCIOLICIDE; ANTIPLATYHELMINTIC AGENT;

ANIMAL EXPERIMENT; ARTICLE; BASEMENT MEMBRANE; BILE DUCT; CONTROLLED STUDY; DRUG EFFICACY; FASCIOLA HEPATICA; FASCIOLIASIS; IN VIVO STUDY; MORPHOLOGY; MUSCLE; NONHUMAN; PARASITE ISOLATION; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SURFACE PROPERTY; SWELLING; SYNCYTIUM; TREMATODE; ANIMAL; ANIMAL DISEASE; DRUG EFFECT; FEMALE; ISOLATION AND PURIFICATION; MALE; METHODOLOGY; PARASITOLOGY; SHEEP; SHEEP DISEASE; TIME; ULTRASTRUCTURE;

FASCIOLA HEPATICA; OVIS ARIES;

ANIMALS; ANTIPLATYHELMINTIC AGENTS; BILE DUCTS; FASCIOLA HEPATICA; FASCIOLIASIS; FEMALE; MALE; MICROSCOPY, ELECTRON, SCANNING; SHEEP; SHEEP DISEASES; TIME FACTORS;

EID: 70349256232     PISSN: 09320113     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00436-009-1453-6     Document Type: Article

References (42)

1. AA Abo-Madyan TA Morsy SM Motawea AT Morsy 2004 Clinical trial of Mirazid in treatment of human fascioliasis, Ezbet El-Bakly (Tamyia Center) Al-Fayoum Governate J Egyptian Soc Parasitol 34 807 818
2. HR Anderson I Fairweather 1995 Fasciola hepatica: ultrastructural changes to the tegument of juvenile flukes following incubation in vitro with the deacetylated (amine) metabolite of diamphenethide Int J Parasitol 25 319 333 7601590 10.1016/0020-7519(94)00105-W 1:CAS:528:DyaK2MXlsVert70%3D
3. CE Bennett 1975 Scanning electron microscopy of Fasciola hepatica L. during growth and maturation in the mouse J Parasitol 61 892 898 1185431 10.2307/3279230 1:STN:280:DyaE28%2Fkslyrtw%3D%3D
4. JC Boray PD Crowfoot MB Strong JR Allison M Schellenbaum M Von Orelli G Sarasin 1983 Treatment of immature and mature Fasciola hepatica infections in sheep with triclabendazole Vet Rec 113 315 317 6649348 1:CAS:528:DyaL2cXislY%3D
5. JF Buchanan I Fairweather G Brennan A Trudgett EM Hoey 2003 Fasciola hepatica: surface and internal tegumental changes induced by treatment in vitro with the sulphoxide metabolite of albendazole ("Valbazen") Parasitology 126 141 153 12636352 10.1017/S0031182002002664 1:CAS:528: DC%2BD3sXit1ChsLY%3D (Pubitemid 36308250)
6. I Fairweather 2005 Triclabendazole: new skills to unravel an old(ish) enigma J Helminthol 79 227 234 16153316 10.1079/JOH2005298 1:CAS:528: DC%2BD2MXhtV2itrrI (Pubitemid 41192536)
7. I Fairweather 2009 Triclabendazole progress report, 2005-2009: an advancement of learning? J Helminthol 15 1 12
8. I Fairweather HR Anderson TMA Baldwin 1987 Fasciola hepatica: tegumental surface alterations following treatment in vitro with the deacetylated (amine) metabolite of diamphenethide Parasitol Res 73 99 106 3575297 10.1007/BF00536464 1:CAS:528:DyaL2sXitVOhsb8%3D (Pubitemid 17087333)
9. Fairweather I, Threadgold LT, Hanna REB (1999) Development of Fasciola hepatica in the mammalian host. In: Dalton JP (ed) Fasciolosis. CAB International Publishing, Wallingford, Oxon, UK, pp 47-111
10. L Favennec J Jave-Ortiz G Gargala N Lopez-Chegne A Ayoub JF Rossignol 2003 Double-blind, randomized, placebo-controlled study of nitazoxanide in the treatment of fascioliasis in adults and children from northern Peru Aliment Pharm Therap 17 265 270 10.1046/j.1365-2036.2003.01419.x 1:CAS:528: DC%2BD3sXhs1WlsLk%3D (Pubitemid 36174258)
11. L Halferty GP Brennan A Trudgett E Hoey I Fairweather 2009 Relative activity of triclabendazole metabolites against the liver fluke, Fasciola hepatica Vet Parasitol 159 126 138 19027238 10.1016/j.vetpar.2008.10.007 1:CAS:528:DC%2BD1MXnsVWjsw%3D%3D
12. L Halferty GP Brennan REB Hanna HW Edgar M Meaney M McConville A Trudgett L Hoey I Fairweather 2008 Tegumental surface changes in juvenile Fasciola hepatica in response to treatment in vivo with triclabendazole Vet Parasitol 155 49 58 18511199 10.1016/j.vetpar.2008.04.011 1:CAS:528:DC%2BD1cXnvVOlsbo%3D
13. REB Hanna 1980 Fasciola hepatica: glycocalyx replacement in the juvenile as a possible mechanism for protection against host immunity Exp Parasitol 50 103 114 7389854 10.1016/0014-4894(80)90012-0 1:STN:280:DyaL3c3isV2ltg%3D%3D (Pubitemid 10023946)
14. FM Haridy MF El Garhy TA Morsy 2003 Efficacy of Mirazid (Commiphora molmol) against fascioliasis in Egyptian sheep J Egyptian Soc Parasitol 33 917 924
15. A Hernández-Campos F Ibarra-Velarde Y Vera-Montenegro N Rivera-Fernandez R Castillo 2002 Synthesis and fasciolicidal activity of 5-chloro-2-methylthio-6-(1-naphthyloxy)-1H-benzimidazole Chem Pharm Bull 50 649 652 12036021 10.1248/cpb.50.649 (Pubitemid 41694935)
16. VF Ibarra MY Vera CA Hernández BR Castillo 1997 Eficacia fasciolicida del compuesto "alfa" contra estadios juveniles y adultos en ovinos Vet Méx 28 297 301
17. VF Ibarra CN Montenegro CJ Flores CA Hernández BR Castillo 2000 Evaluación de cuatro vehículos para formular un fasciolicida experimental Vet Méx 31 47 51
18. VF Ibarra SE García RM Fernández MY Vera BR Castillo CA Hernández 1997 Eficacia fasciolicida de dos compuestos de síntesis química in vitro e in vivo en ovinos Vet Méx 28 291 296
19. J Keiser X Shu-Hua M Tanner J Utzinger 2006 Artesunate and artemether are effective fasciolicides in the rat model and in vitro J Antimicrob Chemother 57 1139 1145 16581915 10.1093/jac/dkl125 1:CAS:528:DC%2BD28XmsFykt7Y%3D (Pubitemid 44644417)
20. J Keiser J Utzinger M Tanner Y Dong JL Vennerstrom 2006 The synthetic peroxide OZ78 is effective against Echinostoma caproni and Fasciola hepatica J Antimicrob Chemother 58 1193 1197 17028093 10.1093/jac/dkl408 1:CAS:528:DC%2BD28Xht1Ogsr7F (Pubitemid 44884138)
21. J Keiser J Utzinger JL Vennerstrom Y Dong G Brennan I Fairweather 2007 Activity of artemether and OZ78 against triclabendazole-resistant Fasciola hepatica Trans R Soc Trop Med Hyg 101 1219 1222 17905370 10.1016/j.trstmh.2007. 07.012 1:CAS:528:DC%2BD1cXkslynsQ%3D%3D (Pubitemid 350047385)
22. S Mas-Coma MD Bargues MA Valero 2005 Fascioliasis and other plant-borne trematode zoonoses Int J Parasitol 35 1255 1278 16150452 10.1016/j.ijpara.2005. 07.010 1:STN:280:DC%2BD2MrivFCnsg%3D%3D (Pubitemid 41395182)
23. M McConville GP Brennan M McCoy R Castillo A Hernández-Campos F Ibarra I Fairweather 2006 Adult triclabendazole-resistant Fasciola hepatica: surface and subsurface tegumental responses to in vitro treatment with the sulphoxide metabolite of the experimental fasciolicide compound alpha Parasitology 133 195 208 16650337 10.1017/S0031182006000114 1:CAS:528: DC%2BD28XmvFCmsLo%3D (Pubitemid 44099907)
24. McConville M, Brennan GP, Flanagan A, Edgar HWJ, Hanna REB, McCoy M, Gordon AW, Castillo R, Hernández-Campos A, Fairweather I (2009a) An evaluation of the efficacy of compound alpha and triclabendazole against two isolates of Fasciola hepatica. Vet Parasitol 162:75-88
25. M McConville GP Brennan A Flanagan HWJ Edgar M McCoy R Castillo A Hernández-Campos I Fairweather 2008 Surface and internal tegumental changes in juvenile Fasciola hepatica following treatment in vivo with the experimental fasciolicide, compound alpha Vet Parasitol 153 52 64 18359570 10.1016/j.vetpar.2008.01.022 1:STN:280:DC%2BD1c3ivVWjsQ%3D%3D
26. McConville M, Brennan GP, Flanagan A, Edgar HWJ, Castillo R, Hernández-Campos A, Fairweather I (2009b) Ultrastructural changes to the tegumental system and the gastrodermal cells in adult Fasciola hepatica following in vivo treatment with the experimental fasciolicide, compound alpha. Parasitology 136:655-680
27. MA McCoy I Fairweather GP Brennan JM Kenny S Ellison AF Forbes 2005 The efficacy of nitroxynil and triclabendazole administered synchronously against juvenile triclabendazole-resistant Fasciola hepatica in sheep Res Vet Sci 78 33 10.1016/j.rvsc.2004.05.008 (Pubitemid 39406730)
28. B McKinstry I Fairweather GP Brennan AB Forbes 2003 Fasciola hepatica: tegumental surface alterations following treatment in vivo and in vitro with nitroxynil (Trodax) Parasitol Res 91 251 263 12937960 10.1007/s00436-003-0930-6 1:STN:280:DC%2BD3svltFWnsg%3D%3D (Pubitemid 37260449)
29. B McKinstry GP Brennan L Halferty AB Forbes I Fairweather 2007 Ultrastructural changes induced in the tegument and gut of Fasciola hepatica following in vivo and in vitro drug treatment with nitroxynil (Trodax) Parasitol Res 101 929 941 17557156 10.1007/s00436-007-0564-1 1:STN:280: DC%2BD2sjhsVyktg%3D%3D (Pubitemid 47228799)
30. Meaney M, Haughey S, Brennan GP, Fairweather I (2005) A scanning electron microscope study on the route of entry of clorsulon into the liver fluke, Fasciola hepatica. Parasitol Res 95:117-128 and 96:189-198
31. M Meaney I Fairweather GP Brennan LSL McDowell AB Forbes 2003 Fasciola hepatica: effects of the fasciolicide clorsulon in vitro and in vivo on the tegumental surface, and a comparison of the effects on young- and old- mature flukes Parasitol Res 91 238 250 12937959 10.1007/s00436-003-0863-0 1:STN:280:DC%2BD3sritlaktA%3D%3D (Pubitemid 37260448)
32. M Meaney J Allister B McKinstry K McLaughlin GP Brennan AB Forbes I Fairweather 2006 Fasciola hepatica: morphological effects of a combination of triclabendazole and clorsulon against mature fluke Parasitol Res 99 609 621 16896655 10.1007/s00436-006-0222-z 1:STN:280:DC%2BD28jjtlKntA%3D%3D (Pubitemid 44337952)
33. M Meaney J Allister B McKinstry K McLaughlin GP Brennan AB Forbes I Fairweather 2007 Fasciola hepatica: ultrastructural effects of a combination of triclabendazole and clorsulon against mature fluke Parasitol Res 100 1091 1104 17180691 10.1007/s00436-006-0378-6 1:STN:280:DC%2BD2srlsVKisg%3D%3D (Pubitemid 46354871)
34. L Mottier L Alvarez L Ceballos C Lanusse 2006 Drug transport mechanisms in helminth parasites: passive diffusion of benzimidazole anthelmintics Exp Parasitol 113 49 57 16430886 10.1016/j.exppara.2005.12.004 1:CAS:528: DC%2BD28XjvVGiurg%3D
35. O'Neill JF, Johnston RC, Halferty L, Brennan GP, Keiser J, Fairweather I (2009) Adult triclabendazole-resistant Fasciola hepatica: morphological changes in the tegument and gut following in vivo treatment with artemether in the rat model. J Helminthol 83:151-163
36. N Ramírez L Mayet L Del Rivero F Ibarra-Velarde R Castillo A Hernández-Campos H Jung-Cook 2009 Pharmacokinetic behaviour in sheep and cattle of 5-Chloro-2-(methylthio)-6-(1-naphthyloxy)-1H-benzimidazole, a new fasciolicide agent J Vet Pharmacol Ther 32 154 159 19290945 10.1111/j.1365-2885. 2008.01014.x
37. FN Rivera VF Ibarra JS Olazaràn MY Vera BR Castillo CA Hernández 2002 Efficacy of 5-chloro-2-methylthio-6-(1-naftiloxi)-ih- benzimidazole against different stages of Fasciola hepatica in Pelibuey sheep Vet Méx 33 55 61
38. MW Robinson A Trudgett EM Hoey I Fairweather 2002 Triclabendazole- resistant Fasciola hepatica: β-tubulin and response to in vitro treatment with triclabendazole Parasitology 124 325 338 11922434 10.1017/S003118200100124X 1:CAS:528:DC%2BD38XlvFWju7g%3D (Pubitemid 34250745)
39. MW Robinson J Lawson A Trudgett E Hoey I Fairweather 2004 The comparative metabolism of triclabendazole sulphoxide by triclabendazole-susceptible and triclabendazole-resistant Fasciola hepatica Parasitol Res 92 205 210 14652740 10.1007/s00436-003-1003-6 (Pubitemid 38230471)
40. PJ Skuce I Fairweather 1990 The effect of the hydrogen ionophore closantel upon the pharmacology and ultrastructure of the adult liver fluke Fasciola hepatica Parasitol Res 76 241 250 2315284 10.1007/BF00930821 1:STN:280:DyaK3c7pt1Ojuw%3D%3D
41. AW Stitt I Fairweather 1993 Fasciola hepatica: tegumental surface changes in adult and juvenile flukes following treatment in vitro with the sulphoxide metabolite of triclabendazole ('Fasinex') Parasitol Res 79 529 536 8278333 10.1007/BF00932235 1:STN:280:DyaK2c7gsFSqtw%3D%3D
42. Toner E, McConvery F, Meaney M, Brennan GP, Fairweather I (2009) A scanning electron microscope study on the route of entry of triclabendazole into the liver fluke, Fasciola hepatica. Parasitology 136:523-535